CURE CLCN4 LTD

Registered charity 1190344 · accounts filings on the Charity Commission register

We are a registered charity aimed at providing support, raising awareness and funding medical research for effective treatments for CLCN4. CLCN4 is a rare genetic condition that causes intellectual disability and other problems such as epilepsy, behavioural disorders, movement disorders and microcephaly.

Objects

THE OBJECTS OF THE CHARITY ARE:(A) THE ADVANCEMENT OF HEALTH, RELIEF OF SICKNESS AND SAVING OF LIVES BY SUCH MEANS AS THE TRUSTEES SEE FIT INCLUDING BUT NOT EXCLUSIVELY THROUGH:(I) PROVIDING RELIEF AND ASSISTANCE TO PEOPLE SUFFERING FROM PATHOGENIC VARIANTS OF CLCN4; AND(II) THE FUNDING OF MEDICAL RESEARCH ANYWHERE IN THE WORLD FOR THE PURPOSE OF DISCOVERING, DEVELOPING AND DELIVERING TREATMENT FOR PATIENTS WITH PATHOGENIC VARIANTS OF CLCN4; AND(B) THE FURTHERANCE OF SUCH OTHER CHARITABLE PURPOSE OR CHARITABLE PURPOSES AS THE TRUSTEES IN THEIR ABSOLUTE DISCRETION FROM TIME TO TIME THINK FIT, IN EACH CASE FOR THE PUBLIC BENEFIT.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: General Charitable Purposes · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Haringey, London, England (from the postcode on the register)

Latest income
£185k
Latest spending
£197k
Registered
2020
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity held free reserves of £(8,657) at the end of the period, which is below the trustees' target of 5–6 months of operating expenditure. The trustees report that this deficit is expected to be replenished in early 2026 by a cash donation from a trustee, and they confirm there are no uncertainties regarding the charity's ability to continue as a going concern.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Donations (77% of income)
“Donations (Note 3) include a £141,681 contribution made by P Trill, a director of the company.” — page 21
Per its FY2025 accounts as filed with the Charity Commission.
Reserves position: below the charity's own stated reserves policy
“At 31 December 2025, the charity held free reserves of £(8,657) (2024: £3,401). This is below the target range set by the Trustees.”
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donations (Note 3) include a £141,681 contribution made by P Trill, a director of the company.
“Donations (Note 3) include a £141,681 contribution made by P Trill, a director of the company. At 31 December 2025, £18,046 (2024 - £18,046) was owed to P Trill in relation to expense payments made on behalf of the company.” — page 21
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Corporate structure

Public fundraising profile: JustGiving — Cure CLCN4 (matched by registered charity number).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£185k£197k
31/12/2024£89k£89k
31/12/2023£78k£119k
31/12/2022£23k£45k
31/12/2021£108k£33k

Common questions

Is CURE CLCN4 LTD financially healthy?

Per its FY2025 accounts: The accounts state that the charity held free reserves of £(8,657) at the end of the period, which is below the trustees' target of 5–6 months of operating expenditure. The trustees report that this deficit is expected to be replenished in early 2026 by a cash donation from a trustee, and they confirm there are no uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.

Who funds CURE CLCN4 LTD?

Funders whose own accounts filings name CURE CLCN4 LTD as a grant recipient include UBS UK Donor-Advised Foundation, HIGHWAY ONE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
UBS UK Donor-Advised FoundationFY2021£98k
HIGHWAY ONE TRUSTFY2024£7k

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE BRAIN CHARITY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
CURE CLCN4 LTD£185k—0below—no doubt
THE BRAIN CHARITY FY2025£1.8m——unclear—no doubt
Chilterns Neuro Centre Ltd FY2025£1.8m—1within—no doubt
CLEVELAND ALZHEIMERS RESIDENTIAL CENTRE LIMITED FY2025£103k—0above—no doubt
THE CHRONIC GRANULOMATOUS DISORDER SOCIETY FY2025£359k—0within41.0%no doubt
CHASING CONNOR'S CURE FY2025£35k——unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.